# Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients

> **NCT00905242** · PHASE4 · COMPLETED · sponsor: **East Carolina University** · enrollment: 61 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** GI medication

## Key facts

- **NCT ID:** NCT00905242
- **Lead sponsor:** East Carolina University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2009-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00905242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00905242, "Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00905242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
